Poly-N-acetyl glucosamine gel matrix as a non-viral delivery vector for DNA-based vaccination

Mohamed L. Salem, Marina Demcheva, William E. Gillanders, David J. Cole, John N. Vournakis

Research output: Contribution to journalReview articlepeer-review

5 Scopus citations


Intramuscular administration of plasmid DNA vaccines is one of the main delivery approaches that can generate antigen specific T cell responses. However, major limitations of the intramuscular delivery strategy are the low level of myocyte transfection, resulting in a minimal level of protein expression; the inability to directly target antigen presenting cells, in particular dendritic cells, which are critical for establishment of efficacious antigen-specific immune responses. Although several viral vectors have been designed to improve plasmid DNA delivery, they have limitations, including the generation of neutralizing antibodies in addition to lacking the simplicity and versatility required for universal clinical application. We have developed an inexpensive non-viral delivery vector based on the polysaccharide polymer poly-N-acetyl glucosamine with the capability to target dendritic cells. This vector is fully biocompatible, biodegradable, and nontoxic. The advantage of the application of this delivery system relative to other approaches is discussed.

Original languageEnglish
Pages (from-to)3889-3894
Number of pages6
JournalAnticancer research
Issue number10
StatePublished - Oct 2010


  • Cytokines
  • IL-12
  • Paracrine treatment
  • SWAP
  • Schistosoma mansoni
  • Systemic treatment
  • Vaccination


Dive into the research topics of 'Poly-N-acetyl glucosamine gel matrix as a non-viral delivery vector for DNA-based vaccination'. Together they form a unique fingerprint.

Cite this